Denali Therapeutics Inc. ($DNLI)
Filing Information
| Accession Number | 0001797826-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 4, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
11,439
Total Value
$261,928.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 2, 2026 | Sale | 10,824 | $22.85 | $247,328.40 | 20,301 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 2, 2026 | Sale | 615 | $23.74 | $14,600.10 | 19,686 | Direct | โ | View Details |